EDN1 and cardiovascular disorder: [14] Produced in excess, ET-1 triggers a series of critical events comprising inflammation, oxidative stress, fibrosis, and cellular phenotypic alterations of the vascular resident cells and infiltrated immune cells which converges to vascular dysfunction and ultimately cardiovascular diseases and downstream complications. [25], [26]